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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A258of the identical (a.p.) view the ICCs were 0.82 (95% CI 0.80-0.84) ranging
from 0.67 to 0.85. Intra-reader reliability was 0.93 (95% CI 0.92-0.94)
ranging from 0.86 to 0.98. Finally, inter-observer reliability was 0.96
(95% CI 0.88-0.99). A decrease in reliability was observed for increasing
voxel sizes. Table 1 gives a detailed overview of the reliability results.
Conclusions: Reliability measurements of FSA showed that the method
is potentially applicable in a clinical setting on a young patient pop-
ulation. However, radiographic technique appears to have a relevant
inﬂuence on reliability including a.p. and p.a. projections, uni- vs.
bilateral image acquisition and repeated measurements acquired in
identical fashion, which was not recognized previously. The inter- and
intra-observer reliability was excellent also in this young clinical cohort,
which conﬁrms previous reports from OA studies.
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IS PHASE-CONTRAST COMPUTED TOMOGRAPHY MORE SENSITIVE
THAN MAGNETIC RESONANCE IMAGING IN QUANTIFYING
CARTILAGE DAMAGE IN OSTEOARTHRITIS?
S. Bairagi y, G. Belev z, D. Chapman y,x, D. Cooper y, W. Dust k,x,
A. Webb z, N. Zhu z, B.F. Eames y,x. yUniv. of Saskatchewan, Dept. of
Anatomy & Cell Biology, Saskatoon, SK, Canada; zCanadian Light Source,
Saskatoon, SK, Canada; xUniv. of Saskatchewan, BioMed. Engineering,
Saskatoon, SK, Canada; kDept. of Surgery, Saskatoon, SK, Canada
Purpose: Articular cartilage, damaged in Osteoarthritis, remains a
challenging tissue to accurately characterize using clinical imaging
techniques. This project quantitatively compares the use of magnetic
resonance imaging (MRI) and synchrotron based phase-contrast-
imaging computed tomography (PCI-CT) in making clinically relevant,
three-dimensional assessments of articular cartilage.
Methods: The medial tibial plateau of disarticulated human knee joints
from four healthy and four osteoarthritic donors was imaged using PCI-
CT at 45 keV and MRI technique, 3D FLASH. The respective pixel reso-
lutions were 28 and 313 micron. Using commercial software, computed
tomography data was manually segmented to generate three-dimensional surface reconstructions of the plateau cartilage, thus per-
mitting quantitation of its total volume and average thickness.
Results: PCI-CT effectively visualizes articular cartilage, differentiating
it from other tissues and surrounding synovial ﬂuid (simulated by a
phosphate buffered saline solution). The ten-fold resolution advantage
of PCI-CT over MRI, allowed for very accurate characterization of
articular cartilage. PCI-CT yielded statistically signiﬁcant lower “average
thickness” measures of articular cartilage compared to MRI.
Conclusions: PCI-CT may be more sensitive than MRI in quantifying
early deterioration of articular cartilage. The knowledge obtained from
this project supports efforts to, eventually, increase the diagnostic and
preventative capabilities in Osteoarthritis. Improved imaging would
enhance the ability to characterize tissue changes that occur in Osteo-
arthritis in vivo, and better relate these changes to patient symptoms.
Inﬂammation and Immunity
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RELATIONSHIP BETWEEN THE GUT MICROBIOTA,
LIPOPOLYSACCHARIDE, INFLAMMATION, AND METABOLIC
OSTEOARTHRITIS DEVELOPMENT: STUDIES IN A RAT MODEL
K.H. Collins, H.A. Paul, R.A. Reimer, R.A. Seerattan, D.A. Hart, W. Herzog.
Univ. of Calgary, Calgary, AB, Canada
Purpose: Western-type diets e high in fat and sugars e often lead to
obesity. Obesity in turn is associated with chronic inﬂammation,
through metabolic dysfunction, which may be a key risk factor for the
onset and increased rate of progression of a metabolic osteoarthritis
(OA) subtype. Growing evidence supports the link between obesity and
changes in the composition of the bacteria that reside in the gastro-
intestinal system, collectively termed the gut microbiota. Recently, the
role of the gut microbiota in activation of the innate immune response,
leading to systemic inﬂammation and OA, has been proposed as a novel,
unexplored mechanism in the context of metabolic osteoarthritis. The
purpose of this set of studies was to evaluate gut microbiota changes
induced by intake of a high fat/high sucrose diet in the context of OA,
and subsequent associations of gut microbial proﬁles with serum and
synovial ﬂuid cytokine and adipokine proﬁles, and knee joint damage.
Methods: Thirty-two male Sprague-Dawley rats (8-12 weeks old) were
randomly separated into two groups: a high fat/high sucrose diet
induced obesity (DIO) (n¼21, 40% fat, Diet #102412, Dyets, Inc) group
and a control (n¼11, LFD, 13.5% fat, LabDiet 5001) group. After a twelve-
week obesity induction period, DIO animals were tertile stratiﬁed into
an Obesity Prone (DIO-P, Top 33% of animals by change in body mass
over twelve weeks, n¼7), and an Obesity Resistant (DIO-R, bottom 33%
of animals by change in body mass over twelve weeks, n¼7) group.
Animals were followed for an additional 16 weeks and sacriﬁced. At
sacriﬁce, synovial ﬂuid and blood were collected and evaluated by Eve
Technologies, Calgary, AB using a Rat Cytokine Array/Chemokine Array
27-Plex Panel (EMD Millipore) detected by Luminex xMAP. OA damage
was determined by a Modiﬁed Mankin Scoring System. Systemic lip-
opolysaccharide (LPS) was evaluated using EndoZyme Recombinant
Factor C Assay (Hyglos GmbH, Germany). Proﬁling of 13 microbial
groups was performed using qPCR. All statistical tests were performed
at a¼0.05.
Results: DIO-P rats were heavier than both DIO-R and chow controls by
week 9 of the obesity induction period and remained heavier through
the remainder of the study (p<0.05). At sacriﬁce, though DIO-R and
chow animals had similar mass (DIO-R: 896 ± 43 g, CHOW 823 ± 19 g,
p¼0.25), both DIO-P and DIO-R animals had increased body fat com-
pared to chow controls at sacriﬁce (DIO-P: 56.7 ± 1.7%, DIO-R: 42.8 ± 1.5
%, CHOW: 29.5 ± 2.5%, p<0.001). All DIO animals had greater Modiﬁed
Mankin scores than lean animals (Median and {Interquartile range}:
DIO: 50 {40-63}, CHOW: 26 {22-38} p¼0.002). There was a positive
signiﬁcant relationship between body fat percentage (r¼0.60, p¼0.001)
and Modiﬁed Mankin score across all animals. However, no statistically
signiﬁcant relationship was found between body mass and Modiﬁed
Mankin score. Despite having more mass, DIO-P animals did not dem-
onstrate higher Modiﬁed Mankin Scores than DIO-R (p¼0.8). Eighteen
synovial ﬂuid analytes and four serum analytes were increased in DIO
animals compared to control animals, and synovial ﬂuid IL-1a was
positively associated with Modiﬁed Mankin Scores across all animals
(r¼0.48, p¼0.03). Circulating LPS levels were higher in all DIO animals
compared to chow animals (LPS DIO 2.18 ± 0.02 log eu/mL, lean 2.06 ±
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A2590.06 log eu/mL, p¼0.04). LPS concentration was associated with body
fat (r¼0.62, p¼0.003), Lactobacillus spp. 16s rRNA gene copy number
(r¼-0.60, p¼0.009), and six serum inﬂammatory markers: GCSF (r¼-
0.49, p¼0.03), serum IL-1a (r¼ -0.48, p¼0.048), IL-4 (r¼-0.52, p¼0.02),
IL-6 (r¼-0.49, p¼0.03), IL-13 (r¼-0.59, p¼0.007), IFNg (r¼-0.49,
p¼0.03). Together, Methanobrevibacter spp. and Lactobacillus spp.
levels had a strong relationship predictive withModiﬁedMankin Scores
when evaluated using linear regression modelling (r2¼0.50, p<0.001).
Conclusions: We found that body fat, not body mass, was associated
with OA damage, and that a distinct inﬂammatory signature in serum
and synovial ﬂuid differentiates obese from lean animals. The source of
this inﬂammation remains to be determined. However, several sig-
niﬁcant relationships between the gut microbiota and local and sys-
temic inﬂammatory markers were identiﬁed. Therefore, we propose
that the link between joint damage and microbiota may be associated
with LPS, which also could explain, in part, the inﬂammatory signatures
evaluated here. Further work is warranted.
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A ROLE FOR CC-CHEMOKINE RECEPTOR 7 (CCR7) IN A MURINE
MODEL OF OSTEOARTHRITIS: IMPACT ON JOINT STRUCTURE AND
FUNCTION
C.R. Scanzello y, J. Gan z, V. Nguyen y, C. Bush-Joseph z, N. Verma z,
S. Chubinskaya z, A.-M. Malfait z, G. Dodge y. yUniv. of Pennsylvania,
Philadelphia, PA, USA; zRush Univ. Med. Ctr., Chicago, IL, USA
Purpose: Synovial inﬂammation is a common but variable feature of
knee osteoarthritis (OA) associated with more severe joint symptoms
and progression of cartilage erosion. However, it is unclear whether
prevention or treatment of synovial inﬂammation will diminish
development of OA. In order to identify potential targets for mod-
iﬁcation of synovial inﬂammation, we previously analyzed synovial
gene expression patterns in patients with meniscal tears. We identiﬁed
a set of chemokine transcripts associated with inﬂammation, which
included the chemokine receptor CCR7 and its two ligands CCL19 and
CCL21. CCR7 plays a central role in development of chronic inﬂamma-
tion. The current study was undertaken to determine if CCR7 plays a
mechanistic role in development of OA-related structural and func-
tional manifestations using a murine model of knee OA induced by
meniscal destabilization.
Methods: To conﬁrm expression of CCR7 in human disease, knee
synovial tissues from 15 patients with meniscal tears, 13 patients with
advanced knee OA, and 9 organ donors without a history of chronic
knee symptoms (asymptomatic donors) were collected through IRB-
approved biorepositories. CCR7 expression was examined by immu-
noperoxidase staining and automated image analysis. To investigate
effects of CCR7 loss in vivo, genetically modiﬁed mice lacking expres-
sion of CCR7 (CCR7-/-), backcrossed onto the C57BL/6 background, were
obtained from Jackson Laboratory. CCR7-/- and C57BL/6 controls were
subjected to DMM surgery (destabilization of the medical meniscus) at
10-12 weeks of age. Six weeks after surgery, groups of 5 mice were
sacriﬁced and knee joints evaluated histopathologically for cartilage
degeneration and osteophyte formation using standard methods.
Changes in spontaneous locomotion and behavior were investigated
longitudinally (up to 16 weeks) after DMM surgery, using the LABO-
RAS® laboratory animal behavior analysis system (Metris B.V., Hoof-
dorp, The Netherlands).
Results: CCR7 staining in synovial tissues was signiﬁcantly higher in
patients with meniscal tears (Mean % area þ/- SEM ¼ 12.26 þ/- 2.4)
compared to asymptomatic donors (3.55 þ/- 2.7, p¼0.01). Six-weeks
after DMM surgery, CCR7-/- mice exhibited reduced cartilage degen-
eration (Mean þ/- SEM ¼ 1.60þ/-0.81) and osteophytes (0.80þ/-0.20)
compared to C57BL/6 controls (cartilage ¼ 5.20þ/-1.06, osteophyte ¼
1.40þ/-0.24, p<0.0001). Decreases in climbing activity post-operatively
were observed inWTmice by 4 weeks post-DMM,and sustained up to 8
weeks. In contrast, CCR7-/- mice maintained pre-operative levels of
climbing activity post-DMM.
Conclusions: In the DMM model of OA, mice deﬁcient in CCR7 showed
reduced structural and functional manifestations of joint degeneration.
Whether these effects are mediated by reductions in synovial inﬂam-
mation will be investigated in future studies. Targeted anti-inﬂamma-
tory treatments aimed at blockade of CCR7 or its ligands should be
tested for both structure- and symptom- modifying effects in future
studies.400
MIA-INDUCED INFLAMMATION AND JOINT PAIN ARE REDUCED IN
TRPA1 DEFICIENT MICE e POTENTIAL ROLE FOR TRPA1 IN
OSTEOARTHRITIS
L.J. Moilanen, M. H€am€al€ainen, E. Nummenmaa, P. Ilmarinen,
R. Nieminen, L. Lehtim€aki, E. Moilanen. The Immunopharmacology Res.
Group, Univ. of Tampere Sch. of Med., Tampere, Finland
Purpose: Injection of monosodium iodoacetate (MIA) into a murine
joint is a widely used experimental model of osteoarthritis (OA). MIA
induces an acute inﬂammation which leads to destruction of articular
cartilage, to hyperalgesia and to decreased weight bearing on the
affected limb indicative for pain. Like in the OA, the detailed mecha-
nisms related to the onset and progression of MIA-induced exper-
imental OA are not understood thoroughly. However, on cellular level
MIA has been recognized to inhibit glyceraldehyde-3-phosphate lead-
ing to production of reactive oxygen species (ROS) and to activation of
caspases and inﬂammatory gene expression.
Transient Receptor Potential Ankyrin 1 (TRPA1) is an ion channel known
to mediate nociceptive signals and neurogenic inﬂammation. It is
activated by various environmental pungent compounds but also by
molecules produced in inﬂammation such as ROS. In the present study
we tested the hypothesis that TRPA1 is involved in MIA-induced acute
inﬂammation and joint pain.
Methods: The effects of pharmacological inhibition (by TCS 5861528)
and genetic depletion of TRPA1 were studied in MIA-induced inﬂam-
mation and joint pain (weight-bearing test) in mouse models. In
addition, the effect of MIA was studied in human primary OA chon-
drocytes and in mouse cartilage.
Results: Intra-articularly injected MIA provoked spontaneous weight
shift away from the affected limb in wild type but not in TRPA1 knock-
out mice referring alleviated joint pain in TRPA1 deﬁcient animals.
Interestingly, mice treated with the selective TRPA1 antagonist TCS
5861528 as well as TRPA1 deﬁcient mice developed tempered inﬂam-
matory response when MIA was injected into the paw indicating that
TRPA1 is involved in the mechanisms of MIA-induced acute inﬂam-
mation. Also, the levels of substance P were diminished in TRPA1 KO
mice and in mice treated with the TRPA1 antagonist, and the MIA-
induced acute response was attenuated by pre-treatment with the
neurokinin 1 receptor antagonist L703,606. Further, cultured human
primary OA chondrocytes expressed TRPA1. Co-stimulation with MIA
and IL-1b increased COX-2 expression which was inhibited by a selec-
tive TRPA1 antagonist, and COX-2 expression was also lower in the
cartilage from TRPA1 knock-out than wild type mice.
Conclusions: TRPA1 mediates MIA-induced inﬂammation and pain in
experimental models supporting the role of TRPA1 as a potential
mediator and drug target in OA.
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HISTOLOGICAL SYNOVITIS AND SYMPTOMS IN PATIENTS WITH
END-STAGE KNEE OSTEOARTHRITIS: A CROSS-SECTIONAL STUDY
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Purpose: Osteoarthritis (OA) of the knee is a slowly progressive age-
related joint disease, which is initially characterized by articular carti-
lage degradation. Although OA was considered to be a non-inﬂamma-
tory condition, the role of synovitis in OA has attracted particular
attention. Recently it is considered that synovial inﬂammation could
play an important role in the pathophysiology of OA. We previously
reported that the cytokine proﬁles expressed in synovium in end-stage
knee OAwere different from those expressed in synovium in early-stage
knee OA. We also previously revealed the symptoms of patients with
end-stage of knee OA who required total knee arthroplasty (TKA)
showed a signiﬁcant correlation with the severity of synovitis in
affected knee joint. On the other hand, no joint structural changes
evaluated by classic radiography were indeed associated with the pain
and symptoms of the patients in our previous study. In addition, it's still
